PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 172 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,732,000 | -3.9% | 62,085 | -16.1% | 0.02% | -19.4% |
| Q2 2020 | $3,882,000 | +44.0% | 73,985 | -8.0% | 0.03% | +24.0% |
| Q1 2020 | $2,695,000 | -31.8% | 80,385 | -7.8% | 0.02% | -7.4% |
| Q4 2019 | $3,949,000 | -3.9% | 87,185 | -19.3% | 0.03% | +8.0% |
| Q3 2019 | $4,111,000 | -3.4% | 107,985 | +10.3% | 0.02% | -13.8% |
| Q2 2019 | $4,257,000 | +155.4% | 97,885 | +123.5% | 0.03% | +141.7% |
| Q1 2019 | $1,667,000 | +5.9% | 43,797 | +19.7% | 0.01% | -7.7% |
| Q4 2018 | $1,574,000 | -65.9% | 36,597 | -61.0% | 0.01% | -62.9% |
| Q3 2018 | $4,610,000 | +21.4% | 93,800 | -20.8% | 0.04% | +34.6% |
| Q2 2018 | $3,798,000 | +1061.5% | 118,500 | +1028.6% | 0.03% | +1200.0% |
| Q1 2018 | $327,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |